FDA Peptide Reclassification 2026: What It Means for Providers 80+ peptides are fda approved. most people aren't using any of them. bpc 157, tb 500, ipamorelin none completed phase 3 trials. the feb 2026 reclassification to category 1 restored compounding access for 14 New FDA Approval GOMEKLI (mirdametinib) Ipamorelin injections are widely talked about, but not FDA approved. Learn the facts before considering any peptide therapy. Zealacademy #Ipamorelin #HormoneHealth #HealthAwareness #AntiAgingTips #FitnessEducation #KnowBeforeYouTry The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Craze Ground Truths